Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness.

Author: MannoB R, MannoJ E, MimsM E, StewartJ J, WoodC D, WoodM J

Paper Details 
Original Abstract of the Article :
In addition to nausea and vomiting, motion sickness involves slowing of brain waves, loss of performance, inhibition of gastric motility and the Sopite Syndrome. The therapeutic effects of antimotion sickness drugs on these reactions were evaluated. The subjects were rotated to the M-III end-point o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/2178599

データ提供:米国国立医学図書館(NLM)

Motion Sickness: Addressing the Secondary Symptoms

The field of [pharmacology] is dedicated to understanding and developing medications that alleviate various symptoms. This research investigates the effectiveness of antimotion sickness medications in addressing secondary symptoms associated with motion sickness, such as brain wave slowing, performance decline, gastric motility inhibition, and the Sopite Syndrome. The authors conducted a study evaluating the effects of various medications on these secondary symptoms. The study found that ephedrine, dimenhydrinate, and metoclopramide were effective in mitigating some of these secondary effects, highlighting the potential of these medications in managing the full spectrum of motion sickness symptoms. The study provides valuable insights into the potential of pharmacotherapy for addressing motion sickness beyond nausea and vomiting.

Expanding the Scope of Motion Sickness Treatment

This study demonstrates the effectiveness of certain medications in addressing secondary symptoms associated with motion sickness, expanding the scope of motion sickness treatment beyond nausea and vomiting. The findings suggest that ephedrine, dimenhydrinate, and metoclopramide may be valuable for managing the full spectrum of motion sickness symptoms, improving the overall well-being of individuals experiencing this condition.

Navigating the Discomfort of Motion Sickness

As a healthcare professional, I am always striving to provide my patients with the best possible care. This study reminds us that motion sickness can manifest in various ways, affecting not only the digestive system but also brain function and overall performance. The findings highlight the importance of considering a comprehensive approach to motion sickness management, addressing both primary and secondary symptoms.

Dr. Camel's Conclusion

Just as a camel navigating a treacherous sandstorm might experience discomfort, individuals prone to motion sickness can encounter a range of symptoms. This study underscores the importance of addressing not only nausea and vomiting but also the secondary effects of motion sickness, offering hope for a more comfortable and fulfilling journey for those prone to this condition.

Date :
  1. Date Completed 1990-04-10
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

2178599

DOI: Digital Object Identifier

2178599

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.